NASDAQ:ATEC - Alphatec Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.27 +0.01 (+0.31 %)
(As of 09/26/2018 04:38 AM ET)
Previous Close$3.26
Today's Range$3.21 - $3.40
52-Week Range$2.20 - $4.27
Volume118,937 shs
Average Volume158,820 shs
Market Capitalization$138.21 million
P/E Ratio-9.08
Dividend YieldN/A
Beta1.19
Alphatec logoAlphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, and Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody Systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Debt-to-Equity Ratio1.11
Current Ratio2.47
Quick Ratio1.67

Price-To-Earnings

Trailing P/E Ratio-9.08
Forward P/E Ratio-5.36
P/E GrowthN/A

Sales & Book Value

Annual Sales$101.74 million
Price / Sales1.36
Cash Flow$0.1485 per share
Price / Cash22.02
Book Value($1.34) per share
Price / Book-2.44

Profitability

EPS (Most Recent Fiscal Year)($0.36)
Net Income$-2,290,000.00
Net Margins-3.32%
Return on Equity-1,326.38%
Return on Assets-4.83%

Miscellaneous

Employees138
Outstanding Shares42,400,000
Market Cap$138.21 million

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How were Alphatec's earnings last quarter?

Alphatec Holdings Inc (NASDAQ:ATEC) posted its quarterly earnings data on Thursday, August, 2nd. The medical technology company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.09. The medical technology company earned $22.04 million during the quarter, compared to the consensus estimate of $22.06 million. Alphatec had a negative return on equity of 1,326.38% and a negative net margin of 3.32%. View Alphatec's Earnings History.

When is Alphatec's next earnings date?

Alphatec is scheduled to release their next quarterly earnings announcement on Thursday, November, 8th 2018. View Earnings Estimates for Alphatec.

What price target have analysts set for ATEC?

2 analysts have issued 12-month price targets for Alphatec's shares. Their forecasts range from $4.00 to $7.00. On average, they anticipate Alphatec's stock price to reach $5.50 in the next year. This suggests a possible upside of 68.2% from the stock's current price. View Analyst Price Targets for Alphatec.

What is the consensus analysts' recommendation for Alphatec?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alphatec.

Who are some of Alphatec's key competitors?

Who are Alphatec's key executives?

Alphatec's management team includes the folowing people:
  • Mr. Patrick S. Miles, Exec. Chairman & CEO (Age 52)
  • Mr. Terry M. Rich, Pres, COO & Director (Age 50)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 54)
  • Mr. Jeffrey P. Rydin, Director (Age 51)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 49)

Who are Alphatec's major shareholders?

Alphatec's stock is owned by many different of retail and institutional investors. Top institutional investors include Stonepine Capital Management LLC (2.13%), HPM Partners LLC (1.21%), Renaissance Technologies LLC (1.14%), Chubb Ltd (1.86%), Fondren Management LP (0.88%) and BlackRock Inc. (0.77%). Company insiders that own Alphatec stock include Brian Snider, Jeffrey G Black, John Foster, Leslie H Cross and Terry Rich. View Institutional Ownership Trends for Alphatec.

Which institutional investors are buying Alphatec stock?

ATEC stock was purchased by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Chubb Ltd, HPM Partners LLC, Fondren Management LP, Renaissance Technologies LLC, Acadian Asset Management LLC, BlackRock Inc. and StepStone Group LP. Company insiders that have bought Alphatec stock in the last two years include Brian Snider, Jeffrey G Black, Leslie H Cross and Terry Rich. View Insider Buying and Selling for Alphatec.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $3.27.

How big of a company is Alphatec?

Alphatec has a market capitalization of $138.21 million and generates $101.74 million in revenue each year. The medical technology company earns $-2,290,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Alphatec employs 138 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is http://www.alphatecspine.com.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]


MarketBeat Community Rating for Alphatec (NASDAQ ATEC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  326
MarketBeat's community ratings are surveys of what our community members think about Alphatec and other stocks. Vote "Outperform" if you believe ATEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/26/2018 by MarketBeat.com Staff

Featured Article: Market Capitalization

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel